Retatrutide Weight Loss Program in Fort Lauderdale | Fusion Wellness FTL
Medical Weight Loss · Fort Lauderdale, FL
Fusion Wellness FTL · · Fort Lauderdale, FL
If you've been researching the next generation of weight loss medications, you've likely come across Retatrutide — and for good reason. Fort Lauderdale patients are increasingly asking our team at Fusion Wellness FTL about this triple-receptor therapy and when they can access it. Here's everything you need to know before your consultation. We are here to answer any questions you have on this. We have started a list of patients interested and you can be at the top of that list! Contact us today if you are interested in Retatrutide!
What Is Retatrutide? A New Class of Weight Loss Treatment
Retatrutide is an investigational weight loss medication developed by Eli Lilly — the same pharmaceutical company behind Mounjaro (tirzepatide). What makes Retatrutide stand apart from every weight loss drug currently on the market is its triple-receptor mechanism: it simultaneously activates GLP-1, GIP, and glucagon receptors.
Think of it as the next evolution beyond Ozempic and Mounjaro. While those medications target one or two hormonal pathways, Retatrutide works on three at once — suppressing appetite, regulating blood sugar, and increasing your body's energy expenditure. It is administered as a once-weekly injection.
Clinical trial data has generated significant excitement in the medical weight loss community. Phase 2 results showed average body weight reductions of 17–24% at higher doses, and Phase 3 TRIUMPH-1 data presented at the 2026 American Diabetes Association Scientific Sessions showed meaningful weight loss maintained across all doses at 80 weeks — results that would make Retatrutide potentially the most effective weight loss medication ever brought to market.
How Retatrutide compares to other GLP-1 therapies: Ozempic/Wegovy targets 1 receptor (GLP-1). Mounjaro/Zepbound targets 2 receptors (GLP-1 + GIP). Retatrutide targets 3 receptors (GLP-1 + GIP + Glucagon) — a first-in-class triple agonist.
Retatrutide FDA Status in 2026: What Fort Lauderdale Patients Must Understand
⚠️ Not Yet FDA Approved — June 2026This is the most important thing to know before you begin your search for Retatrutide in Fort Lauderdale: as of June 2026, Retatrutide has not received FDA approval for weight loss, obesity, or any other indication.
Retatrutide is currently completing Eli Lilly's Phase 3 TRIUMPH clinical trial program. The NDA (New Drug Application) filing is expected in late 2026, with FDA review and potential approval projected for 2027–2028 at the earliest.
Under current federal law, Retatrutide cannot be legally prescribed through standard commercial channels, and compounding pharmacies are prohibited from producing it. Any clinic currently claiming to offer an approved Retatrutide prescription program should be approached with caution.
At Fusion Wellness FTL, we believe in full transparency with our patients. We stay current on all regulatory developments so that when Retatrutide does receive FDA approval, we can offer it immediately and responsibly as part of a medically supervised weight loss program.
Retatrutide vs. Current Weight Loss Medications: How It Stacks Up
| Medication | Receptors Targeted | Avg. Weight Loss | FDA Status (2026) |
|---|---|---|---|
| Ozempic / Wegovy (Semaglutide) |
GLP-1 | ~10–15% | ✅ Approved |
| Mounjaro / Zepbound (Tirzepatide) |
GLP-1 + GIP | ~15–22% | ✅ Approved |
| Retatrutide (Eli Lilly — Investigational) |
GLP-1 + GIP + Glucagon | ~17–24% (Phase 2/3 data) | ⏳ Phase 3 — Approval Est. 2027–28 |
Who Is a Candidate for Retatrutide Weight Loss in Fort Lauderdale?
Based on eligibility criteria used in the TRIUMPH Phase 3 trials, ideal candidates for Retatrutide include adults who:
- Have a BMI of 30 or higher (obesity), or a BMI of 27+ with at least one weight-related health condition
- Have struggled to achieve meaningful results through diet and exercise alone
- Have weight-related conditions such as type 2 diabetes, hypertension, sleep apnea, or high cholesterol
- Are seeking a medically supervised, physician-guided weight loss approach
- Have not found sufficient results with currently available GLP-1 therapies
A comprehensive consultation at Fusion Wellness FTL will assess your full health history, current medications, metabolic markers, and weight loss goals to determine the right treatment path for you — whether that's a currently available GLP-1 therapy today, or Retatrutide once it becomes available.
What Fusion Wellness FTL Offers Fort Lauderdale Weight Loss Patients Right Now
While Fort Lauderdale residents wait for Retatrutide's FDA approval, Fusion Wellness FTL offers a comprehensive medical weight loss program that begins working for you today:
Physician-Supervised GLP-1 Therapy
We offer FDA-approved semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) programs, both of which have shown significant, clinically validated weight loss results. Many of our patients have achieved 15–22% body weight reduction on these programs under proper medical supervision.
Comprehensive Metabolic Evaluation
Before any treatment begins, our team conducts thorough metabolic panels, hormonal assessments, and body composition analysis. Understanding your individual biology is what makes our programs effective — not a one-size-fits-all approach.
Personalized Weight Management Plans
Every patient receives a customized protocol that integrates medication with nutritional guidance, lifestyle coaching, and ongoing monitoring. Weight loss at Fusion Wellness FTL is a whole-body program, not just a prescription.
Retatrutide-Ready When Approval Comes
Patients who begin their weight loss journey at Fusion Wellness now will be first in line when Retatrutide becomes available. We are actively preparing our clinical protocols and provider education so that approval day is launch day for our patients.
Ready to Start Your Weight Loss Journey in Fort Lauderdale?
Don't wait for Retatrutide to start getting results. Schedule a consultation with Fusion Wellness FTL today — our team will build a personalized plan using the most effective options available right now, and keep you at the front of the line for Retatrutide when it's approved.
Book Your Consultation →What to Expect at a Retatrutide Consultation in Fort Lauderdale
Whether you're inquiring about Retatrutide or one of our currently available programs, here's what a first visit at Fusion Wellness FTL in Fort Lauderdale looks like:
- Initial health history review — We review your full medical history, current medications, previous weight loss attempts, and any underlying conditions.
- Metabolic and lab assessment — Bloodwork and metabolic markers help us understand your hormonal and metabolic baseline.
- Treatment recommendation — Your provider will recommend the most appropriate treatment path, whether semaglutide, tirzepatide, or another option, with a clear roadmap toward Retatrutide when available.
- Personalized protocol development — Your program is built around your specific goals, lifestyle, and health status.
- Ongoing support and monitoring — Regular check-ins, dosage adjustments, and lifestyle coaching keep you progressing and safe throughout your program.
Why Fort Lauderdale Patients Choose Fusion Wellness FTL for Medical Weight Loss
Fort Lauderdale has no shortage of wellness clinics, but Fusion Wellness FTL stands apart for patients who want more than a prescription and a follow-up appointment. Here's what our patients consistently tell us makes the difference:
- Physician oversight from day one — Every program is supervised by a licensed medical provider, not delegated to non-clinical staff.
- Transparency about what's approved and what isn't — We will never recommend an unproven or unapproved treatment just to close a sale. Our reputation depends on your results and your safety.
- Whole-body approach — Medication is one tool. We pair it with metabolic evaluation, nutritional guidance, and behavioral coaching for lasting change.
- Fort Lauderdale roots — We're a local practice. Our patients are our neighbors, and we invest in long-term relationships, not one-time visits.
- Staying ahead of the science — From GLP-1 to tirzepatide to Retatrutide, we stay current so our patients always have access to the best available options.
Frequently Asked Questions: Retatrutide in Fort Lauderdale
Retatrutide is a triple-receptor agonist developed by Eli Lilly that activates GLP-1, GIP, and glucagon receptors simultaneously. This triple-action mechanism reduces appetite, improves blood sugar regulation, and increases energy expenditure — making it one of the most powerful weight loss compounds currently in clinical development.
As of June 2026, Retatrutide has not yet received FDA approval. It is currently in Phase 3 clinical trials under Eli Lilly's TRIUMPH program. An NDA filing is expected in late 2026, with potential FDA approval projected for 2027–2028. At Fusion Wellness FTL, we keep patients fully informed on the current regulatory status and offer comparable approved alternatives in the meantime.
Because Retatrutide is not yet FDA approved, it is not available through standard prescription channels in Fort Lauderdale. Fusion Wellness FTL offers consultations to explore all available medically supervised weight loss options and will offer Retatrutide as soon as it receives regulatory approval. Patients who start with us now will be first in line.
Ideal candidates are adults with a BMI of 30 or higher — or BMI 27+ with a weight-related condition like type 2 diabetes or hypertension — who haven't achieved sufficient results with diet and exercise alone. A physician consultation at Fusion Wellness FTL will determine whether you qualify for Retatrutide or a currently available alternative.
Phase 3 TRIUMPH-1 data presented at the 2026 ADA Scientific Sessions showed meaningful weight loss across all doses at 80 weeks. Phase 2 data indicated average body weight reductions of 17–24% at higher doses — results that would make Retatrutide potentially the most effective weight loss medication to reach the market.
Ozempic and Wegovy target only the GLP-1 receptor. Mounjaro and Zepbound (tirzepatide) target GLP-1 and GIP receptors. Retatrutide goes one further — targeting GLP-1, GIP, and glucagon receptors — a triple-action approach that trial data suggests produces greater weight loss than either currently approved option.
Fusion Wellness FTL in Fort Lauderdale offers physician-supervised programs including FDA-approved semaglutide and tirzepatide therapies, comprehensive metabolic evaluations, nutritional coaching, and personalized weight management plans. We will integrate Retatrutide into our programs upon FDA approval.
Fusion Wellness FTL is actively monitoring the Retatrutide approval timeline and preparing to offer it as part of our medical weight loss program once FDA approval is received, currently projected for 2027–2028. In the meantime, we offer consultations to get you started on the most effective options available today.
Take the First Step Toward Your Weight Loss Goals
Fusion Wellness FTL serves Fort Lauderdale and surrounding South Florida communities. Whether you're ready to start a proven GLP-1 program today or want to plan ahead for Retatrutide — our team is here for you.
Schedule Your Consultation →